INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE EVIDENCE INDEX

The Study Library.

8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.

1,146 studies · page 23 of 48

2014 / Narrative review

Research suggests cocoa and dark chocolate may help modulate obesity and body weight via effects on metabolism and satiety.

This review examined the potential role of dark chocolate and cocoa polyphenols in managing obesity. Evidence from animal models, cell cultures, and a small number of human observational and clinical trials indicates promising effects. Suggested mechanisms include decreasing the expression of genes involved in fatty acid synthesis, reducing the digestion and absorption of fats and carbohydrates, and increasing satiety.

Farhat G, Drummond S, Fyfe L, et al. Phytother Res, 2014. PMID 24000103

2014 / Narrative review

A review indicates commonly consumed legumes possess glucose- and lipid-lowering actions and may reduce risk factors for cardiovascular and renal disease.

This paper reviews animal and human studies investigating the glucose- and lipid-lowering effects of various commonly consumed legumes. The authors conclude that various legumes possess varying degrees of antidiabetic potential. Additionally, legumes are reported to be beneficial in decreasing risk factors for cardiovascular and renal disease.

Singhal P, Kaushik G, Mathur P Crit Rev Food Sci Nutr, 2014. PMID 24261538

2014 / Narrative review of epidemiological evidence

A review evaluates epidemiological evidence linking persistent organic pollutants to diabetes development and highlights current evidence gaps.

This review examines the epidemiological evidence linking environmental pollutants, specifically persistent organic pollutants (POPs), to the development of diabetes. The authors note that while lifestyle factors such as poor diet and low physical activity are often cited, evidence linking them to the rapid increase in diabetes and obesity is considered poor. The paper summarizes and appraises current epidemiological studies relating POPs to diabetes while highlighting existing gaps and flaws in the literature.

Shows an association, not proof of cause and effect.

Magliano DJ, Loh VHY, Harding JL, et al. Diabetes Metab, 2014. PMID 24262435

2014 / Narrative review

A review notes that while weight loss benefits NAFLD, diets rich in saturated fats, refined carbohydrates, or very low carbohydrate-high fat intake can worsen it.

This review evaluates the role of weight loss and macronutrient composition, specifically dietary fats and carbohydrates, in treating nonalcoholic fatty liver disease (NAFLD). Lifestyle modifications such as weight loss and exercise are primary clinical approaches, yet certain weight-loss regimens, such as very low carbohydrate, high fat diets, can exacerbate NAFLD and induce insulin resistance. Furthermore, macronutrient composition can alter NAFLD independent of weight change, with diets high in saturated fatty acids or refined carbohydrates exacerbating the condition.

Asrih M, Jornayvaz FR Clin Nutr, 2014. PMID 24262589

2014 / Narrative review

Being born very preterm or very small is linked to cardiometabolic risk factors such as higher blood pressure, lower lean mass, and impaired glucose regulation.

This review examines cardiometabolic risk factors in adults born very preterm or very small. Data suggest an increased risk of type 2 diabetes and accumulating evidence of risk factors including higher blood pressure, lower lean body mass, impaired glucose regulation, and potentially a more atherogenic lipid profile. Adults born very small or very preterm also undertake less non-conditioning physical activity and may consume less fruit and milk products.

Shows an association, not proof of cause and effect.

Kajantie E, Hovi P Semin Fetal Neonatal Med, 2014. PMID 24332842

2014 / Narrative review / perspective

Established views on type 1 diabetes etiology may hamper progress, and clinicians might be wise to recommend lifestyles reducing risks of both T1D and T2D.

This article discusses the classification and etiology of type 1 diabetes (T1D), noting that evidence is weak that an autoimmune process with insulitis causes beta-cell loss in all patients. Proposed triggers include a virus, increased hygiene, or the early introduction of cow's milk or gluten, whereas views regarding nerve supply, vascular function, and the beta cells' own role tend to be disregarded. The author concludes that research needs an open mind and that clinicians might be wise to recommend a lifestyle that aims to decrease both the risk of T1D and type 2 diabetes.

Ludvigsson J Acta Paediatr, 2014. PMID 24344989

2014 / Narrative review

A review reports that dietary factors, the microbiome, and lifestyle changes modestly influence nonalcoholic fatty liver disease.

This review evaluates recent research on how diet, nutrients, and the microbiome contribute to nonalcoholic fatty liver disease (NAFLD). The authors note that fructose appears to be associated with NAFLD severity, while several studies demonstrate that the Mediterranean diet and 'lifestyle change' are effective in modestly improving NAFLD. A study in children reported simultaneous improvements in cardiovascular disease risk measurements and hepatic steatosis. The review concludes that current data supports limiting sugar in the diet and 'lifestyle change' as a first-line treatment for NAFLD, with modest observed benefits.

Vos MB Curr Opin Lipidol, 2014. PMID 24366230

2014 / Narrative review

A review examined evidence linking refined dietary sugar intake to retinal and eye diseases, including diabetic and hypertensive retinopathy.

This review evaluated the current evidence on the relationship between sugar consumption and the development of retinal and eye conditions such as diabetic retinopathy, hypertensive retinopathy, age-related macular degeneration, non-arteritic anterior ischaemic optic neuropathy, and cataract. The authors note that sugar intake has risen five-fold over the past century, driven by sucrose and high-fructose corn syrup in processed foods and soft drinks. Furthermore, the review explores how refined carbohydrates and chronic hyperglycemia impact eye microvascular disease and retinal circulation.

Shows an association, not proof of cause and effect.

Kearney FM, Fagan XJ, Al-Qureshi S Clin Exp Ophthalmol, 2014. PMID 24373051

2014 / Narrative review

A review discusses evidence linking bisphenol A exposure to human chronic diseases such as diabetes, obesity, cardiovascular, kidney diseases, and breast cancer.

Bisphenol-A (BPA) is one of the highest volume chemicals produced worldwide, with over 6 billion pounds produced and over 100 t released into the atmosphere annually. Recent literature has raised concerns regarding BPA's possible implication in the etiology of human chronic diseases, including diabetes, obesity, reproductive disorders, cardiovascular diseases, birth defects, chronic respiratory and kidney diseases, and breast cancer. This review presents evidence on the relationship between BPA exposure and chronic diseases, discussing genetic, epigenetic, and endocrine disruption mechanisms, as well as oxidative stress, mitochondrial dysfunction, and cell signaling.

Shows an association, not proof of cause and effect.

Rezg R, El-Fazaa S, Gharbi N, et al. Environ Int, 2014. PMID 24382480

2014 / Narrative review

Dietary modulation of gut microbiota via whole-plant foods, prebiotics, and probiotics may help manage cardiovascular risk.

This review summarizes evidence connecting gut microbiome activities with cardiovascular disease (CVD) and dietary modulation. Aberrant gut microbiota profiles are linked to obesity, diabetes, and non-alcoholic fatty liver disease, while microbial metabolites from choline, phosphatidylcholine, and l-carnitine directly contribute to CVD pathology. In human studies, selected bile-salt hydrolysing probiotic strains lowered blood cholesterol, and fermentable fibers and plant polyphenols appear to regulate microbial activities. The review concludes that dietary strategies modulating gut microbiota are emerging as efficacious tools for reducing CVD risk, suggesting the way to a healthy heart may be through a healthy gut.

Tuohy KM, Fava F, Viola R Proc Nutr Soc, 2014. PMID 24495527

2014 / Narrative review

A review evaluates human evidence on berries and purified anthocyanins for modulating inflammatory status.

A sustained pro-inflammatory state contributes to chronic conditions such as cardiovascular disease, Alzheimer's, and type 2 diabetes. Berries provide polyphenol compounds, notably anthocyanins, which preclinical data suggest influence inflammatory pathways. This review evaluates the human clinical evidence regarding berry products, extracts, and purified anthocyanins to modulate inflammatory status and reduce chronic disease risk.

Joseph SV, Edirisinghe I, Burton-Freeman BM J Agric Food Chem, 2014. PMID 24512603

2014 / Narrative review

Intestinal microbiota and fecal transplantation are implicated in regulating human glucose and lipid metabolism in insulin resistance and type 2 diabetes.

This review examines the role of intestinal microbiota and fecal transplantation in insulin resistance and type 2 diabetes mellitus. Alterations in intestinal microbiota composition promote systemic inflammation, which is a hallmark of obesity and subsequent insulin resistance. Fecal transplantation studies indicate that butyrate-producing intestinal bacteria are crucial key players in regulating diverse signaling cascades linked to human glucose and lipid metabolism.

Udayappan SD, Hartstra AV, Dallinga-Thie GM, et al. Clin Exp Immunol, 2014. PMID 24528224

2014 / Narrative review

A macrobiotic Ma-Pi 2 diet and prebiotic-rich diets may help manage type 2 diabetes by modulating gut microbiota.

This review discusses the influence of diet, gut microbiota, and inflammation on type 2 diabetes mellitus (T2DM). High-fat diets can promote dysbiosis and inflammation, whereas prebiotics may reduce inflammation, improve insulin resistance, and regulate appetite hormones. A recent 21-day intervention study in T2DM patients reported that the macrobiotic Ma-Pi 2 diet significantly improved fasting blood glucose, plasma lipid fractions, plasma insulin, and homeostasis. The authors note that these effects must be confirmed in larger randomized controlled trials evaluating indicators of inflammation.

Fallucca F, Porrata C, Fallucca S, et al. Diabetes Metab Res Rev, 2014. PMID 24532292

2014 / Narrative review

A review evaluated evidence on meat consumption as a potential clinically useful risk factor for type 2 diabetes.

This article evaluates the evidence supporting meat consumption as a clinically useful risk factor for type 2 diabetes. The evaluation considers studies examining meat consumption as a categorical dietary characteristic, as a scalar variable representing gradations of intake, or as part of a broader dietary pattern. The authors discuss how identifying eating habits as disease risk factors can assist in screening, risk modification, and public health interventions.

Shows an association, not proof of cause and effect.

Barnard N, Levin S, Trapp C Nutrients, 2014. PMID 24566443

2014 / Narrative review

Increasing body mass index from 20-21 kg/m² is linked to higher risks of type 2 diabetes, cardiovascular disease, and several cancers.

This review evaluates basic, clinical, and population research regarding optimal body weight. Epidemiological studies show strong direct associations between increasing BMI and risks of developing type 2 diabetes, cardiovascular disease, and several cancers, beginning from a BMI of 20-21 kg m(-2). Although a recent meta-analysis suggested overweight individuals have lower overall mortality than normal-weight individuals, the authors note this is likely an artifact of methodological issues including smoking confounding, reverse causation, and loss of lean mass in frail elderly individuals.

Shows an association, not proof of cause and effect.

Fontana L, Hu FB Aging Cell, 2014. PMID 24628815

2014 / Narrative review

Obesity is linked to hepatocellular carcinoma via mechanisms including chronic inflammation, lipotoxicity, altered gut microbiota, and insulin resistance.

This review details how obesity and related metabolic conditions contribute to hepatocarcinogenesis. Obesity-associated hepatocellular carcinoma is attributed to chronic inflammation from adipose remodeling, pro-inflammatory adipokine secretion, ectopic lipid accumulation, altered gut microbiota, disrupted stellate cell senescence, and insulin resistance with elevated insulin and insulin-like growth factors. These pathways synergize with chronic liver disease from other etiologies to accelerate hepatocellular carcinoma development.

Shows an association, not proof of cause and effect.

Karagozian R, Derdák Z, Baffy G Metabolism, 2014. PMID 24629562

2014 / Narrative review

A review notes that sugar-sweetened beverage consumption plays a role in the epidemic of obesity, metabolic syndrome, and fatty liver disease.

This narrative review examined data on dietary sugar consumption and related health risks, including NHANES, USDA surveys, meta-analyses, and randomized controlled trials. About 75% of foods and beverages contain added sugar, and soft drink consumption has increased fivefold since 1950. Meta-analyses indicate sugar-sweetened beverage (SSB) intake is related to risks of diabetes, metabolic syndrome, and cardiovascular disease, and drinking two 16-ounce SSBs daily for 6 months induced metabolic syndrome features and fatty liver. Trials lasting 6 months to 2 years showed that lowering soft drink intake reduced weight gain.

Bray GA, Popkin BM Diabetes Care, 2014. PMID 24652725

2014 / Narrative review / counterpoint

Authors argue there is no clear evidence that dietary sugar uniquely impacts the development of obesity or diabetes compared to other calorie sources.

In this counterpoint narrative, the authors respond to arguments proposing reduced dietary sugar consumption to address obesity and type 2 diabetes. They argue that there is no clear or convincing evidence that any dietary or added sugar has a unique or detrimental impact compared to other caloric sources on developing obesity or diabetes. They note sugar is purely a palatable energy source that is not essential, and while cutting sugar can reduce energy intake, doing so does not automatically portend clinical benefit.

Kahn R, Sievenpiper JL Diabetes Care, 2014. PMID 24652726

2014 / Narrative review

A review evaluates evidence linking bisphenol A (BPA) exposure from food packaging to obesity and type 2 diabetes.

This review examines literature investigating the association between bisphenol A (BPA) and alterations in metabolic health. It discusses daily BPA exposure levels, evaluates human epidemiologic data and mechanistic preclinical studies regarding obesity and diabetes, and summarizes current views from regulatory agencies.

Shows an association, not proof of cause and effect.

Mirmira P, Evans-Molina C Transl Res, 2014. PMID 24686036

2014 / Narrative review

A review evaluates human studies investigating the effects of seaweed and its bioactive components on markers of health and chronic disease.

Seaweeds are rich in unique bioactive compounds such as specific proteins, polyphenols, and polysaccharides with purported antiviral, anticancer, anticoagulant, gut health, obesity, and diabetes benefits. Although most research has been conducted in cell and animal models, evidence exists for the beneficial effects of seaweed and seaweed components on markers of human health and disease status. This review critically evaluates these human studies to highlight gaps in current knowledge and support future research planning.

Brown ES, Allsopp PJ, Magee PJ, et al. Nutr Rev, 2014. PMID 24697280

2014 / Review

Iron overload contributes to organ damage in chronic metabolic diseases, while iron depletion can exert beneficial effects.

This review discusses the impact of iron overload on chronic metabolic diseases such as type 2 diabetes, obesity, non-alcoholic fatty liver disease, and atherosclerosis. Iron overload affects glucose and lipid metabolism in tissues like pancreatic β cells, liver, muscle, and adipose tissue, resulting in organ damage. Conversely, iron depletion can exert beneficial effects in patients with iron overload and in healthy frequent blood donors. The authors suggest regular assessment of iron balance for patients with chronic metabolic diseases.

Fernández-Real JM, Manco M Lancet Diabetes Endocrinol, 2014. PMID 24731656

2014 / Narrative review of human and animal studies

Time-restricted feeding is linked to reductions in body weight and improvements in lipid and glucoregulatory markers in animals and humans.

This review summarized the literature on the effects of time-restricted feeding (TRF) on body weight and metabolic disease risk markers in animals and humans. Animal studies showed TRF was associated with reduced body weight, total cholesterol, triglycerides, glucose, insulin, IL-6, and TNF-alpha, alongside improved insulin sensitivity. Human data supported these findings, demonstrating decreased body weight (though not consistently), lower triglycerides, glucose, and LDL cholesterol, and higher HDL cholesterol.

Rothschild J, Hoddy KK, Jambazian P, et al. Nutr Rev, 2014. PMID 24739093

2014 / Narrative review

Dietary factors and gut microbiota dysbiosis appear to influence type 1 diabetes development, though evidence remains inconclusive.

This review examines the influence of dietary and environmental factors, alongside gut microbiota, on type 1 diabetes (T1D) etiology in humans and animal models. Even in mono-zygotic twins, the concordance rate is only around 50%, highlighting the role of non-genetic factors. Although data remain inconclusive, there are strong indications that gut microbiota dysbiosis plays an important role, and animal models suggest manipulating the gut microbiota may be valuable for future prevention in genetically susceptible individuals.

Nielsen DS, Krych Ł, Buschard K, et al. FEBS Lett, 2014. PMID 24746688

2014 / Narrative review

Gut microbiota dysbiosis, including reduced levels of butyrate-producing bacteria, is linked to type 2 diabetes and metabolic alterations.

This review discusses the relationship between gut microbiota, obesity, and type 2 diabetes (T2D). Human metagenome-wide association studies show significant correlations between specific intestinal bacteria, bacterial genes, and metabolic pathways with T2D. Notably, concentrations of butyrate-producing bacteria such as Roseburia intestinalis and Faecalibacterium prausnitzii were lower in T2D subjects. Additionally, gut-derived endotoxaemia is observed in metabolic syndrome and T2D, and specific bacteria like Akkermansia muciniphila may be decreased in diabetes and exert antidiabetic effects in murine models.

Shows an association, not proof of cause and effect.

Tilg H, Moschen AR Gut, 2014. PMID 24833634